A Gene-Based Machine Learning Classifier Associated to the Colorectal Adenoma-Carcinoma Sequence
Antonio Lacalamita1, Emanuele Piccinno1, Viviana Scalavino1
1National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, 70013 Bari, Italy.
Biomedicines
|December 24, 2021
Summary
This study identifies 56 key genes in colorectal cancer (CRC) progression. A six-gene classifier shows potential as an early diagnostic biomarker for CRC, improving upon current methods.
Area of Science:
- Genomics
- Bioinformatics
- Oncology
Background:
- Colorectal cancer (CRC) develops through a stepwise genetic alteration process known as the normal mucosa-adenoma-carcinoma sequence.
- Understanding gene expression changes during this sequence is crucial for early detection and intervention.
Purpose of the Study:
- To develop a predictive classifier for the adenoma-carcinoma transition in CRC using gene expression profiles.
- To identify key differentially expressed genes (DEGs) associated with CRC progression and patient prognosis.
Main Methods:
- Utilized microarray gene expression data from 465 samples (normal, adenoma, CRC) from the Gene Expression Omnibus database.
- Applied sequential Boruta algorithm and Stepwise Regression for feature selection, identifying 56 significant DEGs.
- Employed machine learning algorithms (LM, RF, k-NN, ANN) for classification, with k-NN showing the highest accuracy (88.06%).
- Validated models on an independent cohort, confirming k-NN's superior performance (91.11% accuracy).
Main Results:
- Successfully classified normal, adenoma, and CRC tissues using the 56 selected DEGs.
- Identified 17 DEGs exhibiting a clear expression trend across the normal mucosa-adenoma-carcinoma sequence.
- Selected six DEGs (SCARA5, PKIB, CWH43, TEX11, METTL7A, VEGFA) significantly correlated with patient survival data from TCGA.
Conclusions:
- The k-Nearest Neighbors (k-NN) classifier based on 56 DEGs effectively distinguishes between normal, adenoma, and CRC tissues.
- A novel six-gene classifier holds promise as a potential biomarker for the early diagnosis of colorectal cancer.
- Further validation of this gene signature could lead to improved clinical diagnostic tools for CRC.


